You just read:

BTG to Initiate Multi-Centre TARGET Study Evaluating Dosimetry for 90Y Radioembolisation Therapy in Patients With Hepatocellular Carcinoma

News provided by

BTG Plc

02 Apr, 2016, 08:00 BST